AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28

Authors: KHAN P MCGOWN AT DAWSON MJ JAYSON G PRENDIVILLE JA PETTIT GR CROWTHER D
Citation: P. Khan et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR THE NOVEL ANTITUMORDRUG, BRYOSTATIN-1, INCORPORATING A SERUM EXTRACTION TECHNIQUE, Journal of chromatography B. Biomedical sciences and applications, 709(1), 1998, pp. 113-117

Authors: DUCKI S FORREST R HADFIELD JA KENDALL A LAWRENCE NJ MCGOWN AT RENNISON D
Citation: S. Ducki et al., POTENT ANTIMITOTIC AND CELL-GROWTH INHIBITORY PROPERTIES OF SUBSTITUTED CHALCONES, Bioorganic & medicinal chemistry letters, 8(9), 1998, pp. 1051-1056

Authors: ALEKSANDRZAK K MCGOWN AT HADFIELD JA
Citation: K. Aleksandrzak et al., ANTIMITOTIC ACTIVITY OF DIARYL COMPOUNDS WITH STRUCTURAL FEATURES RESEMBLING COMBRETASTATIN A-4, Anti-cancer drugs, 9(6), 1998, pp. 545-550

Authors: JORDAN A HADFIELD JA LAWRENCE NJ MCGOWN AT
Citation: A. Jordan et al., TUBULIN AS A TARGET FOR ANTICANCER DRUGS - AGENTS WHICH INTERACT WITHTHE MITOTIC SPINDLE, Medicinal research reviews, 18(4), 1998, pp. 259-296

Authors: BROWN S JORDAN AM LAWRENCE NJ PRITCHARD RG MCGOWN AT
Citation: S. Brown et al., A CONVENIENT SYNTHESIS OF THE PACLITAXEL SIDE-CHAIN VIA A DIASTEREOSELECTIVE STAUDINGER REACTION, Tetrahedron letters, 39(21), 1998, pp. 3559-3562

Authors: HADFIELD JA MCGOWN AT
Citation: Ja. Hadfield et At. Mcgown, PREPARATION AND EVALUATION OF DIARYLALKYNES AS ANTITUMOR AGENTS, Synthetic communications, 28(8), 1998, pp. 1421-1431

Authors: WESTERHOF GR BOUDEWIJN A MCGOWN AT HADFIELD JA CORNELISSEN JJ VANLOM K DOWN JD PLOEMACHER RE
Citation: Gr. Westerhof et al., IN-VITRO SENSITIVITY OF PRIMARY CML CELLS FOR BUSULFAN AND BUSULFAN-ANALOGS, British Journal of Haematology, 102(1), 1998, pp. 182-183

Authors: MCGOWN AT JAYSON G PETTIT GR HARAN MS WARD TH CROWTHER D
Citation: At. Mcgown et al., BRYOSTATIN 1-TAMOXIFEN COMBINATIONS SHOW SYNERGISTIC EFFECTS ON THE INHIBITION OF GROWTH OF P388 CELLS IN-VITRO, British Journal of Cancer, 77(2), 1998, pp. 216-220

Authors: DUCKI S HADFIELD JA HEPWORTH LA LAWRENCE NJ LIU CY MCGOWN AT
Citation: S. Ducki et al., SYNTHESIS AND CELL-GROWTH INHIBITORY PROPERTIES OF SUBSTITUTED (E)-1-PHENYLBUT-1-EN-3-ONES, Bioorganic & medicinal chemistry letters, 7(24), 1997, pp. 3091-3094

Authors: WESTERHOF GR PLOEMACHER RE BOUDEWIJN A MCGOWN AT HADFIELD JA DOWN JD
Citation: Gr. Westerhof et al., ENGRAFTMENT-PROMOTING PROPERTIES OF DIMETHANE SULFONATE COMPOUNDS IN CONDITIONING THERAPY FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 25(8), 1997, pp. 295-295

Authors: WRIGLEY E MCGOWN AT WARD TH EWEN C CROWTHER D
Citation: E. Wrigley et al., C-KIT RECEPTORS IN OVARIAN-TUMORS AND THE RESPONSE OF OVARIAN-CARCINOMA CELL-LINES TO RECOMBINANT HUMAN STEM-CELL FACTOR, International journal of gynecological cancer, 6(4), 1996, pp. 273-278

Authors: CUMMINGS J HADFIELD JA MEIKLE I MCGOWN AT SMYTH JF
Citation: J. Cummings et al., MOLECULAR MODELING OF THE INTERACTION OF ANTHRACENYL-AMINO ACID TOPOISOMERASE INHIBITORS WITH THE DNA-SEQUENCE D(CGTACG), Anti-cancer drugs, 7(6), 1996, pp. 636-641

Authors: DUCKI S HADFIELD JA ZHANG XG LAWRENCE NJ MCGOWN AT
Citation: S. Ducki et al., ISOLATION OF AURANTIAMIDE ACETATE FROM ARISAEMA-ERUBESCENS, Planta medica, 62(3), 1996, pp. 277-278

Authors: DUCKI S HADFIELD JA LAWRENCE NJ LIU CY MCGOWN AT ZHANG XG
Citation: S. Ducki et al., ISOLATION OF E-1-(4'-HYDROXYPHENYL)-BUT-1-EN-3-ONE FROM SCUTELLARIA-BARBATA, Planta medica, 62(2), 1996, pp. 185-186

Authors: BREEDEN SW JORDAN AM LAWRENCE NJ MCGOWN AT
Citation: Sw. Breeden et al., 2'-DEACETOXYAUSTROSPICATINE FROM THE STEM BARK OF TAXUS-BACCATA, Planta medica, 62(1), 1996, pp. 94-95

Authors: WRIGLEY EC MCGOWN AT BUCKLEY H HALL A CROWTHER D
Citation: Ec. Wrigley et al., GLUTATHIONE-S-TRANSFERASE ACTIVITY AND ISOENZYME LEVELS MEASURED BY 2METHODS IN OVARIAN-CANCER, AND THEIR VALUE AS MARKERS OF DISEASE OUTCOME, British Journal of Cancer, 73(6), 1996, pp. 763-769

Authors: WRIGLEY E MCGOWN AT RENNISON J SWINDELL R CROWTHER D STARZYNSKA T STERN PL
Citation: E. Wrigley et al., 5T4 ONCOFETAL ANTIGEN EXPRESSION IN OVARIAN-CARCINOMA, International journal of gynecological cancer, 5(4), 1995, pp. 269-274

Authors: BROWN RT FOX BW HADFIELD JA MCGOWN AT MAYALARP SP PETTIT GR WOODS JA
Citation: Rt. Brown et al., SYNTHESIS OF WATER-SOLUBLE SUGAR-DERIVATIVES OF COMBRETASTATIN A-4, Journal of the Chemical Society. Perkin transactions. I, (5), 1995, pp. 577-581

Authors: DUCKI S HADFIELD JA LAWRENCE NJ ZHANG XG MCGOWN AT
Citation: S. Ducki et al., ISOLATION OF PAEONOL FROM AARISAEMA-ERUBESCENS, Planta medica, 61(6), 1995, pp. 586-587

Authors: JAYSON GC CROWTHER D PRENDIVILLE J MCGOWN AT SCHEID C STERN P YOUNG R BRENCHLEY P CHANG J OWENS S PETTIT GR
Citation: Gc. Jayson et al., A PHASE-I TRIAL OF BRYOSTATIN 1 IN PATIENTS WITH ADVANCED MALIGNANCY USING A 24-HOUR INTRAVENOUS-INFUSION, British Journal of Cancer, 72(2), 1995, pp. 461-468

Authors: WOODS JA HADFIELD JA PETTIT GR FOX BW MCGOWN AT
Citation: Ja. Woods et al., THE INTERACTION WITH TUBULIN OF A SERIES OF STILBENES BASED ON COMBRETASTATIN A-4, British Journal of Cancer, 71(4), 1995, pp. 705-711

Authors: MCGOWN AT MURPHY D SWINDELL R CROWTHER D FOX BW
Citation: At. Mcgown et al., CORRELATION OF DRUG RESISTANCE-ASSOCIATED PARAMETERS IN OVARIAN TUMOR-BIOPSIES, International journal of gynecological cancer, 4(4), 1994, pp. 241-249

Authors: HADFIELD JA PAVLIDIS VH MCGOWN AT WHITWORTH C PERRY PJ FOX BW
Citation: Ja. Hadfield et al., STRUCTURE-ACTIVITY STUDIES ON 2-ARYL-4H-3,1-BENZOXAZIN-4-ONES, Anti-cancer drugs, 5(5), 1994, pp. 533-538

Authors: PRENDIVILLE J MCGOWN AT GESCHER A DICKSON AJ COURAGE C PETTIT GR CROWTHER D FOX BW
Citation: J. Prendiville et al., ESTABLISHMENT OF A MURINE LEUKEMIA-CELL LINE RESISTANT TO THE GROWTH-INHIBITORY EFFECT OF BRYOSTATIN-1, British Journal of Cancer, 70(4), 1994, pp. 573-578

Authors: RENNINSON J BAKER BW MCGOWN AT MURPHY D NORTON JD FOX BW CROWTHER D
Citation: J. Renninson et al., IMMUNOHISTOCHEMICAL DETECTION OF MUTANT P53 PROTEIN IN EPITHELIAL OVARIAN-CANCER USING POLYCLONAL ANTIBODY CMI - CORRELATION WITH HISTOPATHOLOGY AND CLINICAL-FEATURES, British Journal of Cancer, 69(3), 1994, pp. 609-612
Risultati: 1-25 | 26-28